When President Trump announced a new deal Friday to lower prescription drug costs, it was the clearest sign yet that he'd paused his commerce secretary's push to slap 100% tariffs on pharmaceuticals that aren't manufactured in the U.S.

Why it matters: Prescription drug policy and tariffs are big priorities of Trump's administration. But after the two issues collided in a conflicting series of White House messages recently, Trump set aside the tariffs idea, which could have made drugs more expensive for many Americans. • "Affordability is the issue. The president gets that," an adviser told Axios.

But the road to that decision was rocky, and showed how Trump's uneven management style — particularly surrounding tariffs — shadows a White House in which policies can be made on the fly, cha

See Full Page